A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2004
12/29/2004	WO2004075783A3 A method for stabilizing blood pressure in hemodialysis subjects
12/29/2004	WO2004074458A3 N-acetylglucosaminyltransferase iii expression in lower eukaryotes
12/29/2004	WO2004065538A3 Protein domain related to deafness, osteoarthritis and abnormal cell proliferation
12/29/2004	WO2004064727A3 Method of cancer treatment using hdac inhibitors
12/29/2004	WO2004053061A3 Methods of therapy and diagnosis using targeting of cells that express lax
12/29/2004	WO2004052914A3 Compositions and methods for inhibiting malaria protease falcipain-2
12/29/2004	WO2004047622A3 Substantially non-immunogenic injectable collagen
12/29/2004	WO2004046332A3 Amplified genes involved in cancer
12/29/2004	WO2004043886A3 Production of pharmaceutically active proteins in sprouted seedlings
12/29/2004	WO2004043500A3 Methods for promoting wound healing and uses thereof
12/29/2004	WO2004039324A3 Anti-hiv (sl9) compounds
12/29/2004	WO2004039309A3 Dc-sign isoforms, related compositions and methods for their use in disease therapy
12/29/2004	WO2004035741A3 Susceptibility gene for myocardial infarction; methods of treatment
12/29/2004	WO2004007682A3 Methods and compositions for modulating t helper (th) cell development and function
12/29/2004	WO2004003564A3 Tumour marker and the use thereof for the diagnosis and treatment of tumour diseases
12/29/2004	WO2004002940A8 Inhibitors of hcv ns5b polymerase
12/29/2004	WO2004001014A3 Osteopontin, oligodendrocytes and myelination
12/29/2004	WO2003104429A3 Genes overexpressed by ovarian cancer and their use in developing novel therapeutics
12/29/2004	WO2003104270A3 Dudulin genes, non-human animal model: uses in human hematological disease
12/29/2004	WO2003101393A3 Antibacterial compounds and methods for treating gram positive bacterial infections
12/29/2004	WO2003097802A3 Cancer-linked gene as target for chemotherapy
12/29/2004	WO2003082370A3 Transcellular drug delivery system
12/29/2004	WO2003025200A3 Methods of using 22417, a novel human aminoprotease family member
12/29/2004	WO2003008621A3 87144, human amino acid transporter family member and uses therefor
12/29/2004	WO2002089747A3 Compositions and methods for the therapy and diagnosis of prostate cancer
12/29/2004	WO2000061774A3 Bone morphogenic proteins
12/29/2004	EP1491632A2 Anti-alphavbeta3 humanized monoclonal antibodies
12/29/2004	EP1491631A1 Method of screening transporter inhibitor
12/29/2004	EP1491628A1 Novel galactose transferases, peptides thereof and nucleic acid encoding the same
12/29/2004	EP1491556A1 Humanized immunoglobulins and their production and use
12/29/2004	EP1491554A1 PEGylated soluble gp130-dimers useful as a medicament
12/29/2004	EP1491553A1 Peptides for the treatment of cancer associated with the human papilloma virus (hpv) and other epithelial tumours
12/29/2004	EP1491550A1 31 human secreted proteins
12/29/2004	EP1491236A1 Controlled release composition comprising lactic acid polymer and hydroxynaphthoic acid, and method of producing the same
12/29/2004	EP1491216A1 Drugs comprising protein forming hollow nanoparticles and therapeutic substance to be transferred into cells fused therewith
12/29/2004	EP1491215A1 Remedies with the use of hollow protein nanoparticles presenting growth factor or the like
12/29/2004	EP1491213A1 C-jun phosphorylation inhibitors
12/29/2004	EP1491208A1 Stabilized liquid polypeptide-containing pharmaceutical compositions
12/29/2004	EP1491206A1 Induction method for cell differentiation
12/29/2004	EP1491205A1 Remedy for hypermyotonia
12/29/2004	EP1490697A2 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 1 (npff1)
12/29/2004	EP1490696A2 Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor (ghs)
12/29/2004	EP1490692A2 Diagnostic and therapeutic use of caps
12/29/2004	EP1490690A2 Novel compositions and methods in cancer associated with altered expression of mcm3ap
12/29/2004	EP1490689A1 Novel compositions and methods in cancer associated with altered expression of prlr
12/29/2004	EP1490686A2 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
12/29/2004	EP1490683A2 Treatment of congestive heart failure with natriuretic peptide and a diuretic
12/29/2004	EP1490519A2 Life sciences business systems and methods
12/29/2004	EP1490506A2 Method for generating primate trophoblasts
12/29/2004	EP1490500A1 Novel compositions and methods in cancer associated with altered expression of tbx21
12/29/2004	EP1490495A2 Bone generation by gene therapy
12/29/2004	EP1490492A2 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor
12/29/2004	EP1490490A2 Antisense iap nucleobase oligomers and uses thereof
12/29/2004	EP1490483A2 In vivo incorporation of unnatural amino acids
12/29/2004	EP1490406A1 Costimulatory molecule and its use
12/29/2004	EP1490404A1 Lactoferrin
12/29/2004	EP1490403A2 Galectin-8and functional derivatives as binding agents for cd44 glycoproteins and methods of use
12/29/2004	EP1490401A1 Vegf peptides and their use
12/29/2004	EP1490400A2 Tenascin-w compositions and uses thereof
12/29/2004	EP1490399A2 Human diabetes-mediating proteins
12/29/2004	EP1490395A1 Mutants of the p4 protein of nontypable haemophilus influenzae with reduced enzymatic activity
12/29/2004	EP1490388A1 Novel compositions and methods in cancer associated with altered expression of kcnj9
12/29/2004	EP1490387A2 A human ribonucleotide reductase m2 subunit
12/29/2004	EP1490386A2 Novel polypeptides and nucleic acids encoding the same
12/29/2004	EP1490385A2 Jagged 2 inhibitors for inducing apoptosis
12/29/2004	EP1490119A1 Tissue treatment
12/29/2004	EP1490109A2 Egfr ligands and methods of use
12/29/2004	EP1490108A2 Drg11-responsive (dragon) gene family
12/29/2004	EP1490107A1 Modulating angiogenesis
12/29/2004	EP1490101A1 Methods of enhancing immune induction involving mda-7
12/29/2004	EP1490097A1 Use of botulinum toxin for treating cardiovascular diseases
12/29/2004	EP1490096A1 Use of hydrogen peroxide producing enzyme for treatment of otitis media
12/29/2004	EP1490095A1 Stable pharmaceutical composition containing factor viii
12/29/2004	EP1490094A1 Antibody fusion proteins: effective adjuvants of protein vaccination
12/29/2004	EP1490092A1 Cosmetic or pharmaceutical composition containing peptides
12/29/2004	EP1490091A1 Enhancement of endogenous gonadotropin production
12/29/2004	EP1490089A1 Peptides selectively lethal to malignant and transformed mammalian cells
12/29/2004	EP1490088A2 Dentritic cell nodes
12/29/2004	EP1490086A2 Use of an organ-specific self-pathogen for treatment of a non-autoimmune disease of said organ
12/29/2004	EP1490085A2 Fc receptor homolog, reagents, and uses thereof
12/29/2004	EP1490084A2 Compositions and methods for regulating thyroid hormone metabolism and cholesterol and lipid metabolism via the nuclear receptor car
12/29/2004	EP1490076A2 Novel metabolic targets and markers
12/29/2004	EP1490075A2 Bioadhesive directed somatic cell therapy
12/29/2004	EP1490074A2 Mixed- cell gene therapy
12/29/2004	EP1490013A2 Methods, compositions, and kits for enhancing oligonucleotide-mediated nucleic acid sequence alteration using compositions comprising a histone deacetylase inhibitor, lambda phage beta protein, or hydroxyurea
12/29/2004	EP1402898B1 Antarticine-nf3 for the treatment and re-epithelialisation of wounds
12/29/2004	EP1343516A4 Analogues of thiocoraline and be-22179
12/29/2004	EP1295230A4 Method and system for foreign exchange price procurement and automated hedging
12/29/2004	EP1255821B1 Protein c derivatives
12/29/2004	EP1242114A4 Use of enzymes for skin expansion
12/29/2004	EP1214345B1 Agents for treating human diseases, especially for treating tumors such as colonic cancers and melanomas or for regenerating tissue and promoting hair growth
12/29/2004	EP1198242A4 Autologous thrombin
12/29/2004	EP1161456B1 Ccr5 binding antibody constructs and their use for treating autoimmune diseases
12/29/2004	EP1123509B1 Methods of diagnosing or prognosing alzheimer's disease
12/29/2004	EP1084251B1 Attenuated pestiviruses
12/29/2004	EP1071768B1 Delivery of therapeutic proteins via implantation of genetically modified cells in the omentum
12/29/2004	EP1066045B1 Mammalian-derived peptides for the treatment of microbial infection
12/29/2004	EP1033953A4 Method of cross-linking keratin-based films, sheets, and bulk materials
12/29/2004	EP1011720B1 Mucosal cytotoxic t lymphocyte responses
12/29/2004	EP1009400B1 Combination therapy comprising atorvastatin and an antihypertensive agent

1 ... 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 ... 3163